Overview Formulation & Drug Delivery
+co-located event:
Discovery Europe 2025

Formulation & Drug Delivery Congress

Join over 1000 cross-industry experts at Formulation & Delivery 2025 connecting pharmaceutical & biotech representatives as well as academia for high-level discussions on the latest innovations in pharmaceutical drugs formulation, drug delivery, RNA development & Peptides and Oligonucleotide design. 

Across two days our programme will include 8 specialised topic areas diving into specific developments within the industry, from formulation strategies for cell and gene therapies, PROTACs and Nanotechnology to the latest advancements in enhancing bioavailability.

Our Formulation & Delivery event will be co-located with Discovery Europe 2025 in Basel. Enjoy the collaboration as we support your engagement with discovery and formulation colleagues to ensure a smoother development of optimised drug products. 

Leading expert scientists working across formulation, drug delivery, bioanalysis, developability, and manufacturing science & technologies, representing global pharmaceutical organisations, leading biotechnology companies and internationally renowned academic institutions. 

Over 50 technical presentations and case studies focused on the critical topics in AI for automated formulations, enhanced drug delivery through vaccines, PROTAC, and exosomes, as well as an exploration of sustainable drug development.

Agenda at a Glance


Day One

  • Track 1: Small Molecule Formulation
  • Track 2: Large Molecule Delivery
  • Track 3: Preformulation Studies

Day Two

  • Track 1: Large Molecule Formulation
  • Track 2: Small Molecule Drug Delivery
  • Track 3: Process Chemistry & Pharmaceutical Materials Analysis

Discovery & Development Europe 2025

Attendees of also have access to Discovery & Development Europe 2025

Explore Discovery & Development Europe 2025: Guiding Biopharma From Target Identification To Clinical Candidate

Connect & collaborate with 1000+ leaders in biology and chemistry at the renowned Discovery & Development Summit in Basel, where we provide a platform to help you make informed pipeline decisions in early R&D & accelerate the route from target identification to novel clinical candidate, ultimately increasing the number of life-saving treatments for those with critical illnesses.

Together with Formulation & Delivery, benefit from an event supporting you to identify potential formulation & delivery bottlenecks and issues before they arise and promoting collaboration to ensure the development of optimised drug products.

  • The programme addresses drug discovery in new modalities such as protein degradation, and case studies on the integration of screening approaches in phenotypic and genomics-based discovery, Organ-on-a-chip and 3D modelling.
  • Examine the latest advancements and emerging trends in developing neurological treatments, including targeted approaches and novel strategies. 
  • Learn about key focus areas in drug design including AI in drug design: in chemical synthesis, target ID capabilities & lead identification/optimisation.

Agenda at a Glance


23rd Annual Drug Discovery Summit & Discovery Chemistry Europe Congress

  • Workshop 1: Organ Modelling
  • Workshop 2: Targeted Protein Degradation
  • Workshop 3: Automation or AI in Medicinal Chemistry and Drug Design

Drug Discovery Summit

  • Day One | Track 1: Identification And Validation Of Novel Targets For Next Generation
    Therapeutics
  • Day One | Track 2: Animal And Disease Modelling, Organoid And Organ On The Chip Based Discovery
  • Day One | Track 3: Discovery on Target – Screening and Genomic Strategies
  • Day Two | Track 1: Phenotypic & Target Based Discovery Approaches

Drug Design & Medicinal Chemistry Summit

  • Day One | Track 1: Computational Drug Design: AI In Chemical Synthesis, Target ID
    Capabilities, Lead Identification, Lead Optimisation, Measuring PK/PD & Prediction
  • Day Two | Track 2: Hit Finding Technologies And Advancements
  • Day Two | Track 3, Part 1: Automation And Synthesis In Organic Chemistry
  • Day Two | Track 3, Part 2: Molecular Drug Design And Med Chem: Innovations
    In Fragment & Structured Based Drug Discovery

6th Annual Neuroscience Drug Development Europe Congress

  • Day One | Track 1: Drug Discovery For Neurodegenerative Disease
  • Day Two | Track 1: Therapeutic Strategies, Enabling Technologies & Biomarker Development

4th Annual Pharmaceutical Mobile Robotics Congress & 3rd Annual SmartLabs Automation Congress

  • Day One | Track 1: Bridging The Gap Between Automation & Digitalisation through FAIR & Digital Transformation 
  • Day One | Track 2: Smart Manufacturing & Digitisation Optimisation
  • Day One | Track 3: Mobile Robotics In R&D Laboratories
  • Day Two | Track 1: Automation with AI/ML & Robotics Tools in Drug Discovery & Development 
  • Day Two | Track 2: Data-Driven Modelling & Data Analytics for Drug Discovery & Development 

 

What to Expect

1000

leading pharma, biotech, & academic delegates

55
hours of presentations, discussions & interactive content
9
hours of networking breaks, including speed networking & refreshments
240
hours of pre-arranged 1-2-1 meetings, facilitating business growth
Interactive Presentations
Exhibition Hall
Networking Drinks
Poster Display
Event App Swapcard

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of experiences

  • Engaging Thought Leadership

    Over 75 dynamic interactive discussions, roundtables, and presentations curated with insights from top industry leaders and experts
  • Global Technological Showcase

    An international exhibition showcasing cutting-edge technologies and services from leading providers in the scientific field.
  • Networking Emphasis

    Unparalleled networking opportunities, including speed networking sessions, a vibrant drinks reception, and informal gatherings to foster meaningful connections
  • Innovative Poster Displays

    Inspiring poster displays and presentations unveiling the latest breakthroughs from emerging biotech, pharma, and academic institutions

Companies Represented Include

Meet Our Expert Speakers

The event brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data, and industry outlooks. Below were some of the featured speakers at Formulation & Delivery 2024: 25 - 26 April 2024, London, UK

Declan Lowney
Director of Stability Sciences,
Janssen R&D
Kajsa Rådevik
Associate Director CMC Regulatory Affairs,
AstraZeneca
Naila El Kechai
Head of Biologics Formulation,
Sanofi
Paul Marshall
Regulatory Affairs Director,
Jazz Pharmaceuticals
Sam Nash
Associate Principal Scientist,
AstraZeneca
Amal Ali Elkordy
Professor,
University of sunderland
Andrew Feilden
Director Analytical Science,
Bicycle TX
Annette Vinther Heydenreich
Principal Scientist,
Symphogen
Ben Forbes
Professor of Pharmaceutics,
King's College London
Cees Van Rijn
Professor,
University of Amsterdam
Charley Wu
Professor of Chemical Engineering,
University of Surrey
Chris Broomell
Head of Analytical Development,
Omega Therapeutics
Chris Cardon
Founder Ziphius Vaccines,
Ziphius Vaccines
Christopher Locher
Chief Executive Officer,
Versatope Therapeutics
Covadonga Paneda
Chief Operating Officer,
Altamiratherapeutics
Dan Bach Kristensen
Scientific Director,
Symphogen
Daniel Tondera
Head of Biology,
Pantherna Therapeutics GmbH
David Workman
Associate Principal Scientist,
AstraZeneca
Elena Sanna
Associate Principal Scientist,
Sixfold Bioscience
Elizabeth Ogden
Process Engineer,
AstraZeneca
Estelle Beguin
Director Technology Research,
Ethris GmbH
Florian Rosenthal
Senior Scientist,
F. Hoffman - La Roche Ltd.
Hyunhong James Min
Senior Scientist,
University of Oxford
Ijeoma Uchegbu
Professor of Pharmaceutical Nanoscience,
University College London
Ildikó Terebesi
Managing Director,
INVITE
Janis Shute
Scientific Director,
University of Portsmouth
Jens Twellmeyer
Associate Director Science & Technology,
Novartis AG
Jerome Mantanus
Head of Materials Science,
UCB Pharma
Jonathan Reid
Professor of Physical Chemistry and Director of the EPSRC,
University of Bristol
Juha Monkare
Sr. Scientist,
J&J
Kamalinder K Singh
Professor of Pharmaceutical Technology and Drug Delivery,
University of Central Lancshire
Koen Raemdonck
Professor,
Ghent University
Mahnoush Bahjat
Associate Director,
AatraZeneca
Martinus Capelle
Scientific Director,
Johnson & Johnson
Maurits Kleijnen
Head of Research,
Intract Pharma
Meike Harms
Lead Scientist,
Merck Healthcare KGaA
Nagy Habib
Lead Clinician and Head of the Department,
Imperial College London
Nathalie Wauthoz
Professor,
Universite Libre de Bruxelles
Per-Olof Wahlund
Specialist,
Novo Nordisk A/S
Philip Rye
Chief Scientific Officer,
AlgiPharma AS
Richard Storey
Principal Scientist,
AstraZeneca
Rikke Dueholm
Senior Scientist,
AstraZeneca
Shayoni Dutta
Principal Data Scientist,
GSK
Simone Vecchi
Associate Director - Drug Product Development Scientific Integrator,
Jnj
Sophie Janbon
Director,
AstraZeneca
Stephen Pham
Senior Vice President,
Avalyn Pharma Inc.
Sune Andersen
Associate Director,
Janssen Pharmaceuticals
Supriyadi Hafiz
Senior Scientist,
Merck Life Science KGaA
Tjasa Vrlinic
PI,
Medincell
Venkatesh Teja Banala
Biopharmaceutics Investigator,
GSK
Vincent Ling
Senior Director,
Takeda Pharmaceuticals
Yngve Mikkelsen
Chief Marketing Officer,
AlgiPharma
Yogeshwar Bachhav
Director,
AiCuris Anti-infective Cures AG

Interested in Sponsoring?

Our extensive and engaged community extends across large, mid-size and emerging companies within the pharma and biotech space, with a dedicated audience spanning a range of specialisms. Whether you have content to share, are looking for ways to enhance your brand visibility or would like to increase engagement with prospective customers, Oxford Global can offer valuable access to your target demographic through our range of event & content services.

Latest Resources

The Future of Sustainable Drug Delivery: Bacterial Cellulose Nanoparticles

Recent research examines the potential application of bacterial cellulose nanoparticles as a sustainable drug delivery method.

Exolvo Biosciences' Approach to Advancing Oral Biologics Drug Delivery

NLC Health Ventures collaborates with Verily, a precision health tech company, to launch Exolvo Biosciences: an up-and-coming biotech delivering next generation solution for biologics drug delivery.

CRISPR 2.0 - Improving Drug Delivery Through Ultracompact CRISPR Systems

New genome editing methods are building on the capabilities of CRISPR/Cas9. The CasMINI is the latest technology that aims to safely and efficiently deliver genetic therapies to patients.

Innovative Foam Technology Enhances Gene Therapy Delivery

Researchers at the Fred Hutch Cancer Center conducted a study investigating the potential of medicated foam as a gene therapy delivery vector. Their studies showed that a foam-based delivery system enhances the efficiency and safety of gene therapy by ensuring concentrated, controlled release of therapeutic agents.

Freeze-Drying 2.0: Examining the Potential of Thin Film Freezing

TFF Pharmaceuticals and the Cleveland Clinic team up to advance multivalent influenza vaccine candidates into preclinical phases.

Investigating the Potential of Inhaled Biologics in Treating Idiopathic Pulmonary Fibrosis

Positive results from Aileron Therapeutics' ongoing Phase Ib clinical trial gives hope to patients diagnosed with idiopathic pulmonary fibrosis (IPF).

Plan Your Visit

Full details regarding accommodation, travel directions, health and safety, and other logistical information for the event will be added here in the coming months.

Register Your Interest

Submit your details and a member of our team will be in touch